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Abstract
Background: Rotaviruses with G6P[14] specificity are mostly isolated in cattle and have been established as a rare
cause of gastroenteritis in humans. This study reports the first detection of G6P[14] rotavirus strain in Ghana from
the stool of an infant during a hospital-based rotavirus surveillance study in 2010.
Methods: Viral RNA was extracted and rotavirus VP7 and VP4 genes amplified by one step RT-PCR using gene-specific
primers. The DNA was purified, sequenced and genotypes determined using BLAST and RotaC v2.0. Phylogenetic tree
was constructed using maximum likelihood method in MEGA v6.06 software and statistically supported by
bootstrapping with 1000 replicates. Phylogenetic distances were calculated using the Kimura-2 parameter model.
Results: The study strain, GHA-M0084/2010 was characterised as G6P[14]. The VP7 gene of the Ghanaian strain
clustered in G6 lineage-III together with artiodactyl and human rotavirus (HRV) strains. It exhibited the highest
nucleotide (88.1 %) and amino acid (86.9 %) sequence identity with Belgian HRV strain, B10925. The VP8* fragment of
the VP4 gene was closely related to HRV strains detected in France, Italy, Spain and Belgium. It exhibited the strongest
nucleotide sequence identity (87.9 %) with HRV strains, PA169 and PR/1300 (Italy) and the strongest amino acid
sequence identity (89.3 %) with HRV strain R2775/FRA/07 (France).
Conclusion: The study reports the first detection of G6P[14] HRV strain in an infant in Ghana. The detection of G6P[14],
an unusual strain pre-vaccine introduction in Ghana, suggests a potential compromise of vaccine effectiveness and
indicates the necessity for continuous surveillance in the post vaccine era.
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Background
Group A rotaviruses (RVAs) are the leading cause of se-
vere, dehydrating, acute diarrhoea in children <5 years
of age worldwide and are estimated to be responsible for
453,000 deaths annually, with a disproportionate number
of these deaths occurring in sub-Saharan Africa and
South East Asia [1]. The World Health organization
(WHO) recommended global use of rotavirus vaccines
as one of the effective interventions to reduce RVA-
associated diseases [2]. Currently, two RVA vaccines,
RotaTeq (Merck & Co., Inc., United States) and Rotarix
(GlaxoSmithKline Biologicals, Belgium) have been li-
censed and introduced into routine childhood immun-
isation programmes.
Rotavirus, a genus of the Reoviridae family, contains a
genome of 11 segments of double-stranded RNA
(dsRNA) and are classified in a binary system based
upon the main neutralization antigens, namely, the spike
protein (VP4) and the major outer capsid glycoprotein
(VP7) [3]. VP7 and VP4 nucleotide sequences define G
and P genotypes, respectively, and carry independent
neutralization-specific epitopes [3]. Recently, the Rota-
virus Classification Working Group (RCWG) proposed
an extensive RVA classification system that takes into ac-
count all 11 rotavirus genome segments [4]. Prior to the
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present study, at least 27 G genotypes and 37 P geno-
types have been identified globally and approximately 73
G/P genotype combinations of rotaviruses have been re-
ported to infect humans [5]. Among these, only six G/P-
genotype combinations; G1P[8], G2P[4], G3P[8], G4P[8],
G9P[8] and G12P[8] account for most of the HRV
strains detected globally [6]. However, several epidemio-
logical studies have reported the sporadic detection of
unusual rotavirus G-genotypes (G5-G6, G8, G10, G11
and G20) and P-genotypes (P[1]-P[3], P[5], P[7], P[9]-
P[11], P[14], P[19] and P[25]) in humans [3, 6, 7]. Many
of these unusual rotavirus genotypes believed to be of
animal origin have been introduced into the human
population through interspecies transmission and/or
reassortment events [3, 8].
Rotaviruses with G6 specificity are recognised as com-
mon serotype in cattle and other ruminants and have been
found to be an infrequent cause of human disease.
Bovine-like human G6 rotavirus strains PA151 and PA169
were first identified in 1987 and 1988 respectively from
two Italian children hospitalised with acute gastroenteritis
[9]. These two strains were characterised as G6P[9] (strain
PA151) and G6P[14] (strain PA169). Subsequently, an in-
creasing number of G6 HRV strains have been detected in
combination with other P genotypes across the globe
(Hungary, Australia, United States and India) [10–13]. G6
HRV strains are reported to be found mainly in combin-
ation with P[14] rotaviruses (commonly detected in ante-
lope, cattle, rabbits, goats, sheep and guanacos) [14].
Previous reports in Africa, documented the isolation of
G6 rotavirus strains only in animals [15]. The first detec-
tion of G6P[14] HRV strain in Africa was in 2004 from
the stool of a child from Egypt [7].
In our previous study, rotavirus was detected in the
stool of a four month old child hospitalised with severe,
acute dehydrating gastroenteritis at Maamobi Polyclinic
in Accra, Ghana in August 2010. This sample exhibited
the classical human rotavirus group A migration pattern
(4-2-3-2) with a long electrophoretype by Polyacrylamide
Gel Electrophoresis (PAGE) (data not shown). However,
the amplified VP7 and VP8* fragment of the VP4 gene
could not be genotyped using the routine HRV genotype
specific primers. In this study, the G and P genotypes of
strain GHA-M0084/2010 were identified by sequencing.
Results
The study strain GHA-M0084/2010 was characterised as
G6P[14]. Phylogenetic analysis showed the VP7 gene of
the Ghanaian G6P[14] strain clustered in lineage III to-
gether with randomly selected artiodactyl and human
G6 strains (Fig. 1). It clustered in G6 lineage-III together
with HRV strains isolated in Italy (RVA/Hu/PA5/89,
RVA/Hu-tc/ITA/PA169/1988), Belgium (RVA/Hu/BEL/
B10925/1997), and with artiodactyl strain, (RVA/Cap-
rine/CAP455) isolated in South Africa (Fig. 1). The VP7
gene of the study strain shared the strongest nucleotide
(88.1 %) and amino acid (86.9 %) sequence identity with
the Belgian HRV strain, B10925 detected in 1997.
Fig. 1 Phylogenetic tree constructed from nucleotide sequence of Ghanaian G6 strain GHA-M0084/2010 and reference G6 strains by the maximum
likelihood method using MEGA 6.06 software and rooted with the G2 human rotavirus strain, DS-1. Variation scale (nucleotide substitution per site) is
indicated below the phylogenetic tree. Percentage bootstrap support is indicated by values at each node, and values ≥70 % are shown. Study strain
GHA-M0084/2010 is indicated by a filled green square. Reference sequences used in the analysis were obtained from the GenBank database. Phylogenetic
distance was measured by Kimura two-parameter model. Phylogenetic tree was supported statistically by bootstrapping with 1000 replicates
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Table 1 Comparison of nucleotide and amino acid sequence identity of Ghanaian G6 and published G6 strains
Nucleotide identity (%)
RV STRAIN G-TYPE PA169 AG6 ASG6 MG6 PA5 B10925 BA356 48-BF PA77 N-1 Hun5 Hun4 ROBVP7G NCDV Hun7 BoRo4 PA27 Hun3 GHA-M0084
PA169 G6 94.9 96.5 97.5 97.2 97.8 79.2 78.8 96.1 85.1 86.2 79.8 82.5 82 79.5 80.1 79.9 79.8 87.1
AG6 G6 96.7 97.2 97.1 94.1 94.5 76.9 76.5 93.3 83.9 85.2 78.4 81.4 81 77.2 78.8 78 78.4 85
ASG6 G6 99.1 96.7 98.7 96 96.1 78.6 78.2 95.2 85.8 86.5 79.5 82.6 82.4 78.4 79.9 79.4 79.5 86.2
MG6 G6 99.5 97.1 99.5 96.7 97.1 78.8 78.4 95.9 86.3 86.5 79.8 83.2 82.5 79.1 80.2 79.9 79.8 87.1
PA5 G6 98.7 96.3 98.7 99.1 97.1 79.8 79.4 98 85.4 86.3 79.9 83.2 82.5 79.9 80.2 80.2 79.9 87.7
B10925 G6 98.7 96.3 98.7 99.1 99.1 78.8 78.4 96.5 86.3 86.3 79.5 83.3 82.6 79 79.7 79.5 79.5 88.1
BA356 G6 92.2 89.3 92.6 92.2 91.4 91.4 99.5 79.7 78.8 78.6 86.2 79.8 80.2 96 85.9 93.4 86.2 74.9
48-BF G6 92.2 89.3 92.6 92.2 91.4 91.4 100 79.2 78.4 78.7 86.3 79.7 80.1 96.1 85.8 93.5 86.3 74.9
PA77 G6 99.1 96.7 99.1 99.5 99.5 99.5 91.8 91.8 85.4 86.5 79.9 83.1 82.8 79.8 80.1 80.1 79.9 87.6
N-1 G6 96.7 94.2 96.7 97.1 96.7 96.7 92.6 92.6 97.1 84.4 80.1 83.6 82.6 79.9 79.8 79.9 80.1 79.2
Hun5 G6 98.3 95.9 98.3 98.7 98.3 98.3 91.8 91.8 98.7 97.1 81.7 81.8 80.2 79.7 81.3 79.9 81.7 78.7
Hun4 G6 92.6 89.7 92.6 92.6 91.8 92.2 93.4 93.4 92.2 92.2 92.2 81 80.5 86.1 98.6 88.2 100 75.2
ROBVP7G G6 93 90.6 92.2 92.6 92.6 92.6 89.3 89.3 93 92.2 91.8 89.7 93.7 79.9 80.6 80.3 81 76.5
NCDV G6 91.8 89.3 91 91.4 91.4 91.4 88.9 88.9 91.8 91 90.6 89.3 95.9 80.3 80.2 80.7 80.5 75.8
Hun7 G6 93 90.2 92.6 93 92.2 92.2 98.7 98.7 92.6 93.4 92.6 93.8 90.2 89.7 85.4 95 86.1 75
BoRo4 G6 92.6 89.7 92.2 92.6 91.8 92.2 93 93 92.2 92.2 92.2 99.1 89.7 89.3 93.8 88.2 98.6 75
PA27 G6 92.6 89.7 92.2 92.6 91.8 91.8 97.1 97.1 92.2 93.4 92.2 94.2 90.6 90.2 97.9 94.2 88.2 75.2
Hun3 G6 92.6 89.7 92.6 92.6 91.8 92.2 93.4 93.4 92.2 92.2 92.2 100 89.7 89.3 93.8 99.1 94.2 75.2
GHA-M0084 G6 85.7 83.2 85.7 86.1 86.1 86.9 80.4 80.4 86.5 85.7 85.7 81.2 81.2 80 81.2 81.2 80.8 81.2
Amino acid identity (%)












However, it shared very low nucleotide (74.9 %) and
amino acid (74.9 %) sequence identity with West African
isolates BA356 (Cameroon) and 48-BF (Burkina Faso)
(Table 1).
Phylogenetic analysis of the VP8* fragment of the VP4
gene of the Ghanaian strain showed it clustered together
with the prototype HRV strain, PA169-88 and published
HRV strains from other parts of the world (Fig. 2). It
also clustered together with bovine strains, Bov/86 and
RUBV81 (India) and lama guanaco strain, Chubut
(Argentina) (Fig. 2). The Ghanaian VP4 gene shared the
strongest nucleotide sequence identity (87.9 %) with Ital-
ian HRV strains PA169 and PR/1300 and the strongest
amino acid sequence identity (89.3 %) with R2775/FRA/
07 isolated in France (Table 2). However, it shared nu-
cleotide sequence identity of ≥87.0 % ≤89.3 % with ran-
domly selected human and animal rotavirus reference
strains detected in Italy (111-05-27), France (R2775/
FRA/07), India (Bov/86 & RUBV81) and in Egypt
(EGY3399).
Discussion
G6 rotaviruses have been found to be an infrequent
cause of human disease. Their detection in the human
population was suggestive of zoonotic transmission as
they have been detected almost exclusively in artiodac-
tyls such as cattle [8, 14]. We report the detection of a
G6P[14] rotavirus strain in Ghana from the stool of an
infant participating in a hospital-based diarrhea surveil-
lance study conducted in 2010 (pre-vaccine era). This
strain was detected in a locality where the human popu-
lation live in close proximity with their cattle, goats,
sheep and pigs. This setting and proximity provide an
ideal environment for dual RV infections from human
and animal sources which can lead to reassortment of
genes and eventual generation of novel strains.
Phylogenetic analysis of the VP7 gene of the study
strain (GHA-M0084/2010) showed clustering with artio-
dactyl and human G6 strains in lineage III (Fig. 1). The
Ghanaian strain displayed the strongest nucleotide and
amino acid sequence identity (74.9–88.1 % and 80.0–
86.9 % respectively) to randomly selected non-African
reference strains (Table 1). It exhibited the lowest nu-
cleotide identity (74.9 %) to African HRV strains, BA356
(Cameroon) and 48-BF (Burkina Faso) both isolated in
2010 (Table 1). The VP8* fragment of the VP4 gene of
the study strain clustered together with HRV strains de-
tected in France (2007), Italy (1988), Spain (2007) and
Fig. 2 Phylogenetic tree constructed from nucleotide sequence of Ghanaian P[14] strain GHA-M0084/2010 and reference P[14] strains by the maximum
likelihood method using MEGA 6.06 software and rooted with the G4P[6] rotavirus strain RVA/Bov/P14-3/SLOV/G4P6. Variation scale (nucleotide substitution
per site) is indicated below the phylogenetic tree. Percentage bootstrap support is indicated by values at each node, and values ≥70 % are shown. Study
strain GHA-M0084/2010 is indicated by a filled green square. Reference sequences used in the analysis were obtained from the GenBank database.
Phylogenetic distance was measured by Kimura two-parameter model. Phylogenetic tree was supported statistically by bootstrapping with 1000 replicates
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Table 2 Comparison of Amino acid and Nucleotide identity of Ghanaian P[14] and published P[14] rotavirus strains
Amino acid identity (%)
RV STRAIN P-TYPE MG6 Hun5 PA169 HAL1166 LRU62150 B10925 PR/1300 GHA-M0084 111-05-27 R2775 Bov/86 RUBV81 EGY3399 BP1879 Sp1524 Sp813 P14-3 B137
MG6 P[14] 68.9 68.1 60.9 50 70.4 68.9 62.6 68.9 68.9 69.1 68.4 65.4 53.7 73.1 65.9 26.4 75.1
Hun5 P[14] 88.6 86.3 68.4 52.9 85.6 87.8 73.1 92.4 89.3 87.9 88.7 90.2 55.9 70.1 82.5 24.2 69.9
PA169 P[14] 89.1 95.2 68.4 49.2 92.4 84 73.8 83.3 93.1 83.4 84.2 82.7 55.9 73.1 84 25 71.4
HAL_1166 P[14] 86 88.9 89.1 48.5 69.1 67.6 64.4 64.6 69.1 69.4 70.1 68.4 72.1 65.6 66.1 23.5 63.9
LRU62150 P[14] 80.1 80.8 79.7 79.4 50 52.2 45.9 52.9 47.7 52.5 53.2 51.4 51.4 50.3 47 20.7 50.7
B10925 P[14] 89.6 94.8 97.4 89.1 79.7 84 73.8 82.5 91.6 82.7 83.4 81.9 59.7 77.6 89.3 25 76.6
PR/1300 P[14] 88.9 95.9 94.8 88.6 80.8 94.5 73.1 86.3 87.8 84.9 85.7 84.2 56.7 69.4 78 24.2 68.4
GHA-M0084 P[14] 83.2 87.7 87.9 83.9 75.4 87.7 87.9 70.8 76.8 72.5 72.5 71.1 50.7 64.4 70.8 25.7 62.9
111-05-27 P[14] 88.9 97.4 94.1 87.2 80.4 93.6 95.2 87 86.3 84.9 85.7 89.4 58.2 68.6 80.3 25.7 67.6
R2775 P[14] 88.9 96.4 97.6 89.1 79.4 96.9 96.2 89.3 95.2 87.9 88.7 87.2 57.4 72.3 83.3 25 71.4
Bov/86 P[14] 88.9 95.5 94.1 89.1 80.6 93.6 94.8 87.9 94.3 95.7 99.2 85.8 59.2 71.1 75.9 24.8 70.1
RUBV81 P[14] 88.4 95.5 94.1 89.1 81.1 93.6 94.8 87.7 94.3 95.7 99.5 86.5 60 71.8 76.6 24.1 70.8
EGY3399 P[14] 88.2 96.2 94.3 89.3 80.8 93.8 94.5 87.2 95.5 95.5 95 95 59.7 67.9 79.6 25.7 66.9
BP1879 P[14] 78.7 79.9 79.9 85.3 75.2 80.8 80.4 74.7 80.8 80.6 80.8 80.8 81.1 60.7 53.7 20.7 58.9
Sp1524 P[14] 89.6 89.6 90.3 86.7 79 91.5 89.3 84.4 88.6 90.3 89.3 89.3 88.4 80.4 73.8 21.4 91.7
Sp813 P[14] 85.6 91.2 92.2 85.6 76.6 94.1 90 85.1 90.3 91.7 88.9 88.9 90.5 76.1 88.3 25.1 72.1
P14-3 P[14] 54.2 54.4 54.9 53.7 50.9 54.9 54 53.5 55.8 54.4 54.7 54.4 54.7 50.4 52.1 52.3 22.8












Belgium (1997) (Fig. 2). It displayed the strongest aa
(89.3 %) sequence identity to HRV strain R2775 isolated
in France and nt (87.9 %) sequence identity to HRV
strains PA169 and PR/1300 isolated in Italy (Table 2).
Two paediatric rotavirus vaccines (Rotarix and RotaTeq)
are available and have been introduced into national
immunization programmes in many countries [16, 17].
The monovalent vaccine, Rotarix, comprises a human
G1P[8] rotavirus strain, whereas the pentavalent vaccine,
RotaTeq, (a human-bovine reassortant vaccine) comprises
human serotypes G1, G2, G3, G4, and P[8] on a bovine
strain background. Both vaccines demonstrated broad
protection against the most common RVA genotypes [18].
However, their efficacy is low especially on the African
continent with diverse pool of strain types [19, 20].
G6P[14] strain detected in this study shares neither G-
nor P-genotype with either of the two current vaccines.
Though, other rotavirus proteins such as VP6 and NSP4
have been identified to play a role in the protective im-
munity against rotavirus infection, it is unknown whether
Rotarix will provide protection against completely hetero-
typic G6P[14], an animal-derived human rotavirus strain.
Conclusion
In this study, we determined the VP7 and VP4 genotypes
of previously non-typeable rotavirus strain. The study re-
ports for the first time the detection of G6P[14] rota-
virus strain in a child in West Africa. Data on the
impact of rotavirus vaccination globally has shown that
two rotavirus vaccines, RotaTeq™ and Rotarix™, provide
good homotypic and heterotypic protection. However,
there are concerns about the degree of protection these
vaccines provide against rare/unusual rotavirus strains
such as G6P[14] that bears G/P genotype specificities
not included in the vaccines. The detection of a G6P[14]
strain pre-vaccine introduction in Ghana, suggests a po-
tential compromise of vaccine effectiveness and indicates
the necessity for continuous surveillance in the post vac-
cine era.
Methods
Viral RNA extraction and reverse transcription
Viral RNA was extracted from 10 % faecal suspension in
phosphate buffered saline using the QIAamp viral RNA
Mini kit (Qiagen/Westburg, Leusden, The Netherlands).
PCR primer pairs, 9Con1/9Con2 and VP4-F/VP4-R
(Additional file 1: Table S1) were used in one step RT-
PCR to target the VP7 gene and the VP8* fragment of
the VP4 gene to generate 903 and 663 bp respectively
[21, 22]. PCR products were purified using the Exo-SAP-
IT clean up kit (Affymetrix, Miles Rd Cleveland, OH,
USA). Products were directly sequenced for VP7 and
VP4 genes using the Bigdye terminator sequencing kit
v3.1 (Perkin-Elmer Applied Biosystems, Foster City, CA,
USA) on an automated Genetic analyzer ABI PRISM
3130 (Applied Biosystems).
Nucleotide sequence and phylogenetic analysis
Chromatograms were visually inspected and edited. Geno-
types were determined using the Basic Local Alignment
Search Tool [BLAST] (http://blast.ncbi.nlm.nih.gov/Blas-
t.cgi) and confirmed with RotaC v2.0 genotyping tool [23].
Edited sequences were trimmed and homology table was
constructed using Bioedit v.7.0.5. The nucleotide se-
quences of the study strain were aligned with randomly
selected cognate gene sequences available in GenBank
using the ClustalW algorithm [24]. Two rotavirus refer-
ence strains; HRV serotype G2 (RVA/Human-tc/USA/DS-
1/1976/G2) and bovine G4P[6] (RVA/Bov/P14-3/SLOV/
G4P[6]) were included in the phylogenetic trees as out-
groups for the VP7 and VP4 genes respectively (Figs. 1
and 2). Phylogenetic trees were constructed using the
maximum likelihood method in MEGA v6.06 programme
[25] and statistically supported by bootstrapping with
1000 replicates. Pyhlogenetic distances were calculated
using the Kimura-2 parameter model.
Nucleotide sequence accession number
The nucleotide sequences of the strain reported in this
study (GHA-M0084/2010) have been deposited in the
GenBank database under accession numbers KJ616414
and KJ616415 respectively.
Additional file
Additional file 1: Table S1. List of primers used in this study.
(DOCX 16 kb)
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